# Xenetic Biosciences, Inc.: Form 8-K, filed Mar 13, 2026

- Company: [Xenetic Biosciences, Inc.](/companies/xbio.md) (CIK 1534525)
- Form: 8-K
- Filed: 2026-03-13
- Accepted by EDGAR: Mar 13, 2026, 08:00 ET
- Period: 2026-03-13
- Accession: 0001683168-26-001744
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1534525/000168316826001744/xenetic_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534525/000168316826001744/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534525/000168316826001744/xenetic_8k.htm

Filed Mar 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001683168-26-001744. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.
